In vivo evidence of immunological masking of the Vibrio cholerae O antigen of a hybrid Salmonella typhi Ty21a-Vibrio cholerae oral vaccine in humans
- PMID: 1716810
- DOI: 10.1016/0264-410x(91)90039-9
In vivo evidence of immunological masking of the Vibrio cholerae O antigen of a hybrid Salmonella typhi Ty21a-Vibrio cholerae oral vaccine in humans
Erratum in
- Vaccine 1991 Dec;9(12):915
Abstract
The immunogenicity of the live oral hybrid vaccine organism Salmonella typhi Ty21a/V. cholerae Inaba (EX210) following its growth in media containing variable concentrations of supplemental galactose was examined in human volunteer subjects. The local intestinal IgA-specific antibody responses to both typhoid and cholera lipopolysaccharide (LPS) preparations were determined. It was observed that the immunogenicity of the galactose-independent Vibrio cholerae O antigen in vivo was dependent upon the variation in galactose-dependent long chain S. typhi O antigen production which was directly proportional to the media galactose concentration. It is likely that this observation was a result of steric hindrance of the presentation of the V. cholerae O antigen by S. typhi Ty21a in the presence of the longer, immunodominant S. typhi Ty21a O antigen. This observation may have relevance to the use of S. typhi vectors in vaccine development involving the presentation of LPS-associated heterologous antigens.
Similar articles
-
Surface co-expression of Vibrio cholerae and Salmonella typhi O-antigens on Ty21a clone EX210.Microb Pathog. 1990 Mar;8(3):177-88. doi: 10.1016/0882-4010(90)90045-r. Microb Pathog. 1990. PMID: 1696342
-
Characterization and immunogenicity of EX880, a Salmonella typhi Ty21a-based clone which produces Vibrio cholerae O antigen.Infect Immun. 1991 Jul;59(7):2279-84. doi: 10.1128/iai.59.7.2279-2284.1991. Infect Immun. 1991. PMID: 1711014 Free PMC article.
-
Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a.Infect Immun. 1990 Jun;58(6):1620-7. doi: 10.1128/iai.58.6.1620-1627.1990. Infect Immun. 1990. PMID: 1692807 Free PMC article.
-
A review of the current status of enteric vaccines.P N G Med J. 1995 Dec;38(4):325-31. P N G Med J. 1995. PMID: 9522876 Review.
-
The development of a bivalent vaccine against diarrhoeal disease.Southeast Asian J Trop Med Public Health. 1988 Sep;19(3):449-57. Southeast Asian J Trop Med Public Health. 1988. PMID: 2464195 Review.
Cited by
-
Influence of different rol gene products on the chain length of Shigella dysenteriae type 1 lipopolysaccharide O antigen expressed by Shigella flexneri carrier strains.J Bacteriol. 1997 Apr;179(7):2421-5. doi: 10.1128/jb.179.7.2421-2425.1997. J Bacteriol. 1997. PMID: 9079931 Free PMC article.
-
Development of Shigella sonnei live oral vaccines based on defined rfbInaba deletion mutants of Vibrio cholerae expressing the Shigella serotype D O polysaccharide.Infect Immun. 1996 Feb;64(2):576-84. doi: 10.1128/iai.64.2.576-584.1996. Infect Immun. 1996. PMID: 8550210 Free PMC article.
-
Oral vaccines for preventing cholera.Cochrane Database Syst Rev. 2011 Mar 16;2011(3):CD008603. doi: 10.1002/14651858.CD008603.pub2. Cochrane Database Syst Rev. 2011. PMID: 21412922 Free PMC article.
-
Vaccination of adults against travel-related infectious diseases, and new developments in vaccines.Infection. 1993 Jan-Feb;21(1):1-17. doi: 10.1007/BF01739302. Infection. 1993. PMID: 8449574 Review.
-
Recombinant avirulent salmonellae as oral vaccine carriers.Infection. 1992 Jan-Feb;20(1):1-8. doi: 10.1007/BF01704884. Infection. 1992. PMID: 1563805 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous